New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Search Results for
Top Eight Asia Biopharma Clusters 2017
June 30, 2017
... One of the year's biggest deals came in February, when Takeda Pharma completed its $5.2 billion acquisition of ARIAD Pharmaceuticals. Also in February, home-grown Asahi Glass ...
BE Licenses Takeda's Measles and Pertussis Vaccines for India...
June 26, 2017
Biological E. (BE) negotiated two licensing agreements with Takeda for the latter's ... Takeda has sold both the vaccines in Japan for more than 20 years. The agreements give ...
Numerate to Use AI Platform in Developing Drugs for Takeda |...
June 12, 2017
Takeda Computational drug design company Numerate said today it will use its artificial intelligence (AI) platform to identify and deliver multiple clinical candidates for Takeda ...
Takeda Negotiates Right to Buy GammaDelta for T-Cell Immunotherapeutic...
May 9, 2017
GEN News Highlights More » May 9, 2017 Takeda Negotiates Right to Buy GammaDelta for T-Cell Immunotherapeutics Platform Takeda has negotiated an exclusive right to acquire ...
Wearables Add Value to Clinical Trials
May 1, 2017
In late February, CognitionKit (a joint venture between Cambridge Cognition and Ctrl Group) partnered with Takeda Pharmaceuticals USA to evaluate how well a wearable technology ...
Takeda, Harrington Discovery Institute Launch Rare Disease Collaborati...
April 27, 2017
GEN News Highlights More » April 27, 2017 Takeda, Harrington Discovery Institute Launch Rare Disease Collaboration Takeda Pharmaceutical will partner with Harrington Discovery ...
Takeda Slicing Ariad Workforce After Acquisition
March 30, 2017
GEN News Highlights More » March 30, 2017 Takeda Slicing Ariad Workforce After Acquisition Takeda Pharmaceutical has absorbed only part of the nearly 300-employee workforce it ...
Icahn Names Gene Transfer Pioneer as Portfolio Manager
March 3, 2017
M.D., into retirement from the helm of Ariad Pharmaceuticals, the cancer drug developer that he founded in 1991 and is being acquired by Takeda Pharmaceutical for $5.2 billion. Dr. ...
Top 10 Wall Street Winners of 2016
February 6, 2017
jumping nearly 116% before announcing on January 9 that it is being acquired by Takeda Pharmaceutical for approximately $5.2 billion. #10. Argos Therapeutics NASDAQ: ARGS ...
Takeda, Ovid to Co-Develop Rare Pediatric Epilepsy Candidate...
January 18, 2017
GEN News Highlights More » January 18, 2017 Takeda, Ovid to Co-Develop Rare Pediatric Epilepsy Candidate TAK-935 Takeda Pharmaceutical said its rare pediatric epilepsy candidate ...